Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Musculoskelet Surg ; 101(Suppl 2): 145-151, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28756508

RESUMEN

BACKGROUND: Arthroscopic subscapularis (SSC) repair is a technically demanding procedure with a long learning curve. As effective completion of resident's practical experience remains controversial, a prospective clinical study was performed to assess the functional and anatomical outcomes of subscapularis (SSC) arthroscopic repair by orthopedic residents. The pathological anatomy of the tears, the surgical approach and the difficulties encountered at the beginning of the learning curve were reported. MATERIALS AND METHODS: Between June 2009 and June 2010, 30 patients with rotator cuff tear were preoperatively evaluated with clinical exam, Constant and UCLA scores. Surgery was performed under arthroscopy by a team of three orthopedic surgeons in training. A SSC tear, if present, was recorded and treated. The same clinical exam and functional scores were repeated at minimum 6 months of follow-up. Subscapularis strength recovery and tendon healing were investigated with arthromagnetic resonance imaging. RESULTS: A SSC tear was observed in 11 cases out of 30 and treated arthroscopically. The clinical scores improved in all patients: the average Constant score increased from 34 ± 14 to 77 ± 11 and the UCLA score from 11 ± 5 to 29 ± 3. The SSC tests were negative in all patients with the exception of one. Tendon healing was observed in 10 out of 11 cases. CONCLUSIONS: Arthroscopic SSC repair performed by educated residents is possible and leads to good clinical and anatomical results. Surgery duration progressively improved as the learning curve advanced. LEVEL OF EVIDENCE: Level 2.


Asunto(s)
Artroscopía/educación , Internado y Residencia , Curva de Aprendizaje , Ortopedia/educación , Lesiones del Manguito de los Rotadores/cirugía , Adulto , Anciano , Artroscopía/métodos , Femenino , Estudios de Seguimiento , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Tempo Operativo , Satisfacción del Paciente , Estudios Prospectivos , Lesiones del Manguito de los Rotadores/diagnóstico por imagen , Lesiones del Manguito de los Rotadores/rehabilitación , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Cicatrización de Heridas
2.
J Gene Med ; 3(3): 228-39, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11437328

RESUMEN

BACKGROUND: Melanomas of the uveal tract are the most common intraocular malignancies in adults, with an incidence of six cases per million adults per year. Enucleation, which may enhance the dissemination of tumour cells into the systemic circulation, is still required for eyes with large tumours. Gene therapy is proposed as a new therapeutic approach for uveal melanoma management. METHODS: The potential of adenovirus-mediated gene transfer to normal eyes of two laboratory Beagles and in an iris tumour of a Great Dane were evaluated. Replication-defective adenoviral vectors (Adbetagal) were used to assess the feasibility, efficiency and safety of direct adenoviral delivery to the anterior chamber of normal eyes and to an iris tumour. The expression of angiostatin into the aqueous humour following an adenoviral-mediated delivery of human angiostatin (AdK3) was also investigated. RESULTS: The ciliary body was the area preferentially transduced after adenoviral injection into the anterior chamber. It was also demonstrated that a direct intratumoral injection of a recombinant adenovirus efficiently transduces a canine uveal melanoma. Western blot analysis performed on the aqueous humour revealed that the expression of the angiostatin recombinant protein in the aqueous humour correlated with the dose of AdK3 administered. Lymphocyte infiltrates at the site of AdK3 injection indicated induction of a strong cellular immune response, and humoral immune responses developed in all three dogs. CONCLUSIONS: The present study involving adenovirus-mediated gene transfer to dog eyes provides an essential basis for gene therapy treatment of uveal melanoma-bearing patients.


Asunto(s)
Adenoviridae/genética , Técnicas de Transferencia de Gen , Terapia Genética/métodos , Vectores Genéticos/genética , Neoplasias de la Úvea/terapia , Adenoviridae/inmunología , Angiostatinas , Animales , Cámara Anterior/virología , Formación de Anticuerpos , Humor Acuoso/metabolismo , Modelos Animales de Enfermedad , Perros , Estudios de Factibilidad , Terapia Genética/tendencias , Vectores Genéticos/inmunología , Humanos , Fragmentos de Péptidos/genética , Plasminógeno/genética , Neoplasias de la Úvea/genética , Neoplasias de la Úvea/patología
3.
Cancer Res ; 61(8): 3450-7, 2001 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-11309307

RESUMEN

The tissue inhibitor of metalloproteinases-2 (TIMP-2) has at least two independent functions, i.e., regulation of matrix metalloproteinases and growth promoting activity. We investigated the effects of TIMP-2 overexpression, induced by retroviral mediated gene transfer, on the in vivo development of mammary tumors in syngeneic mice inoculated with EF43.fgf-4 cells. The EF43.fgf-4 cells established by stably infecting the normal mouse mammary EF43 cells with a retroviral expression vector for the fgf-4 oncogene, are highly tumorigenic and overproduce vascular endothelial growth factor (VEGF). Despite a promotion of the in vitro growth rate of EF43.fgf-4 cells overexpressing timp-2, the in vivo tumor growth was delayed. At day 17 post-cell injection, the volume of tumor derived from TIMP-2-overexpressing cells was reduced by 80% as compared with that obtained with control cells. Overexpression of TIMP-2 was associated with a down-regulation of VEGF expression in vitro and in vivo, a reduction of vessel size, density, and blood supply in the induced tumors. In addition, TIMP-2 completely inhibited the angiogenic activity of EF43.fgf-4 cell-conditioned medium in vitro using a rat aortic ring model. Our findings suggest that overexpression of TIMP-2 delays growth and angiogenesis of mammary carcinoma in vivo and that down-regulation of VEGF expression may play an important role in this TIMP-2-mediated antitumoral and antiangiogenic effects. Finally the in vivo delivery of TIMP-2, as assessed by i.v. injection of recombinant adenoviruses vectors, significantly reduced the growth of the EF43.fgf-4-induced tumors. This effect of TIMP-2 was shown to be equally comparable with that of angiostatin, a known potent inhibitor of angiogenesis.


Asunto(s)
Factores de Crecimiento Endotelial/biosíntesis , Linfocinas/biosíntesis , Neoplasias Mamarias Experimentales/irrigación sanguínea , Neoplasias Mamarias Experimentales/patología , Neovascularización Patológica/patología , Inhibidor Tisular de Metaloproteinasa-2/fisiología , Adenoviridae/genética , Angiostatinas , Animales , División Celular , Regulación hacia Abajo , Factores de Crecimiento Endotelial/genética , Femenino , Factores de Crecimiento de Fibroblastos/genética , Técnicas de Transferencia de Gen , Linfocinas/genética , Neoplasias Mamarias Experimentales/metabolismo , Ratones , Ratones Endogámicos BALB C , Neovascularización Patológica/genética , Neovascularización Patológica/metabolismo , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/fisiología , Plasminógeno/genética , Plasminógeno/fisiología , Ratas , Inhibidor Tisular de Metaloproteinasa-2/biosíntesis , Inhibidor Tisular de Metaloproteinasa-2/genética , Células Tumorales Cultivadas , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial Vascular
4.
Gene Ther ; 7(9): 790-6, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10822306

RESUMEN

A recombinant MVMp of the fibrotropic strain of minute virus of mice (MVMp) expressing the chloramphenicol acetyltransferase reporter gene was used to infect a series of biologically relevant cultured cells, normal or tumor-derived, including normal melanocytes versus melanoma cells, normal mammary epithelial cells versus breast adenocarcinoma cells, and normal neurons or astrocytes versus glioma cells. As a reference cell system we used normal human fibroblasts versus the SV40-transformed fibroblast cell line NB324K. After infection, we observed good expression of the reporter gene in the different tumor cell types, but only poor expression if any in the corresponding normal cells. We also constructed a recombinant MVMp expressing the green fluorescent protein reporter gene and assessed by flow cytometry the efficiency of gene transduction into the different target cells. At a multiplicity of infection of 30, we observed substantial transduction of the gene into most of the tumor cell types tested, but only marginal transduction into normal cells under the same experimental conditions. Finally, we demonstrated that a recombinant MVMp expressing the herpes simplex virus thymidine kinase gene can, in vitro, cause efficient killing of most tumor cell types in the presence of ganciclovir, whilst affecting normal proliferating cells only marginally if at all. However, in the same experimental condition, breast tumor cells appeared to be resistant to GCV-mediated cytotoxicity, possibly because these cells are not susceptible to the bystander effect. Our data suggest that MVMp-based vectors could prove useful as selective vehicles for anticancer gene therapy, particularly for in vivo delivery of cytotoxic effector genes into tumor cells.


Asunto(s)
Terapia Genética/métodos , Vectores Genéticos/administración & dosificación , Virus Diminuto del Ratón/genética , Neoplasias/terapia , Transfección/métodos , Adenocarcinoma/terapia , Animales , Neoplasias de la Mama/terapia , Femenino , Glioma/terapia , Herpesvirus Humano 1/enzimología , Humanos , Melanocitos , Melanoma/terapia , Ratas , Timidina Quinasa/genética , Células Tumorales Cultivadas
5.
Rocz Panstw Zakl Hig ; 51(4): 385-92, 2000.
Artículo en Polaco | MEDLINE | ID: mdl-11286089

RESUMEN

Results of the study performed between June 1999 and January 2000 on dietary assessment of 822 pre-school children (age 3-7) showed that majority of children regularly consumed the main meals: breakfast, dinner and supper. The habit of snacks eating between the meals was observed in 91% of children. The presence and structure basic products in analysed children diets (milk, fermented milk products, fats, fish, whole grain bread, juices) was different. About 87% reported drinking of milk, 75%--yoghurt or other fermented milk products, 97%--fruit juices including nectar, water--42%. The main fat used to spreading on bread was butter. Fish products recommended as a source of n-3 polyunsaturated fatty acids were still not eaten by 23% of children. Whole grain bread was consumed daily only in 8% children. The study also showed that the diets included products being the source of unfavourable fatty acids (chips, sweet bars, cookies, hard margarine) and excess of saccharose (sweets, lollipops, chewing gum). The results of the study showed the permanent need of the dissemination of dietary recommendations for children at pre-school age.


Asunto(s)
Conducta Alimentaria , Evaluación Nutricional , Niño , Preescolar , Grasas de la Dieta/análisis , Proteínas en la Dieta/análisis , Análisis de los Alimentos , Humanos , Polonia , Sacarosa/análisis
6.
Bull Mem Acad R Med Belg ; 154(6 Pt 2): 377-80, 1999.
Artículo en Francés | MEDLINE | ID: mdl-10992887

RESUMEN

We developed a suicide gene therapy protocol for the treatment of brain tumors. This protocol is based on the expression of the thymidine kinase gene of Herpes simplex virus: this protein is toxic for dividing cells in the presence of specific drugs such as acyclovir or gancyclovir. We developed an adenoviral vector to transfer and express the viral thymidine kinase into experimental C6 tumors implanted in Wistar rat brain. Rats were then treated with injection of gancyclovir and we observed significant reduction in tumor growth and an increase in survival for the treated rats as compared to control animals (injected with the corresponding buffer). Furthermore, no major side effects were noticed.


Asunto(s)
Adenoviridae/genética , Neoplasias Encefálicas/terapia , Modelos Animales de Enfermedad , Terapia Genética/métodos , Vectores Genéticos/uso terapéutico , Glioma/terapia , Simplexvirus/genética , Adenoviridae/enzimología , Animales , Evaluación Preclínica de Medicamentos , Trasplante de Neoplasias , Ratas , Ratas Wistar , Simplexvirus/enzimología , Timidina Quinasa/genética
7.
J Biol Chem ; 273(44): 28931-6, 1998 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-9786896

RESUMEN

Recombinant adenoviruses were used for the expression of human amyloid precursor protein (APP) of Alzheimer's disease in primary cultures of rat cortical neurons and astrocytes. The catabolic pathways of human APP were studied 3 to 4 days after infection, when the equilibrium of APP production was reached. Although the expression of human wild type APP (WtAPP) by rat neurons induced the production of both extracellular and intraneuronal amyloid peptide (Abeta), Abeta was not detected in the culture medium of rat astrocytes producing human WtAPP. Because a low beta-secretase activity was previously reported in rodent astrocytes, we wondered whether modifications of the APP amino acid sequence at the beta-secretase clipping site would modify the astrocytic production of Abeta. Interestingly, rat astrocytes produced high amounts of Abeta after expression of human APP carrying a double amino acid substitution responsible for Alzheimer's disease in a large Swedish family (SwAPP). In both rat cortical neurons and astrocytes, the beta-secretase cleavage of the human SwAPP occurred very early in the secretion process in a cellular compartment in which a different sorting of SwAPP and WtAPP seems unlikely. These results suggest that human WtAPP and SwAPP could be processed by different beta-secretase activities.


Asunto(s)
Adenoviridae/genética , Precursor de Proteína beta-Amiloide/metabolismo , Astrocitos/enzimología , Corteza Cerebral/enzimología , Endopeptidasas/metabolismo , Neuronas/enzimología , Secretasas de la Proteína Precursora del Amiloide , Precursor de Proteína beta-Amiloide/genética , Animales , Ácido Aspártico Endopeptidasas , Corteza Cerebral/citología , Humanos , Ratas , Recombinación Genética , beta-Galactosidasa/genética
8.
Gene Ther ; 4(1): 25-31, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9068792

RESUMEN

The toxicity of the suicide HSVtk gene approach is known to be targeted to DNA synthesis and, consequently, to dividing cells. This system is therefore useful for the treatment of brain tumors which contain dividing cells surrounded by a quiescent normal tissue. Adenoviruses are efficient vectors for the transfer of the HSVtk gene into the tumor but this can lead to the transduction of quiescent cells. In this study, we focused on the toxicity of the HSVtk/ganciclovir treatment for the two main cell types of the normal brain: astrocytes and neurons. Astrocytes and neurons in primary culture were infected by an adenoviral vector bearing the HSVtk gene (Ad.tk) and cells were exposed to different concentrations of ganclclovir. After 5 days of treatment, an MTT test measured a dramatic decrease in cell viability for treated astrocytes while a small decrease in cell viability was observed for neurons treated in the same experimental conditions. The differential toxicity of the HSVtk/ganciclovir treatment was also observed in cocultures of astrocytes and neurons: an immunocytochemical analysis of the treated cells showed major morphological modifications for astrocytes but not for neurons. Furthermore, our data suggest that a bystander effect is able to kill all the astrocytes while neurons from the same culture remain unaffected.


Asunto(s)
Antivirales/toxicidad , Astrocitos/efectos de los fármacos , Ganciclovir/toxicidad , Terapia Genética/métodos , Neuronas/efectos de los fármacos , Timidina Quinasa/genética , Adenoviridae , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Técnicas de Cocultivo , Vectores Genéticos , Inmunohistoquímica , Ratas , Simplexvirus/enzimología
9.
Hautarzt ; 47(6): 454-8, 1996 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-8767661

RESUMEN

We report a case of epidermodysplasia verruciformis (EV) with typical cutaneous manifestations in light-exposed areas. The diagnostic criteria were the characteristic macular lesions, the virus transformed keratinocytes on histological examination and the detection of human papillomavirus (HPV) DNA by a nested-PCR approach for EV-associated types. In this case we found HPV-type 5, the most common type of HPV in EV, directly by sequencing and sequence analysis.


Asunto(s)
Epidermodisplasia Verruciforme/patología , Papillomaviridae/clasificación , Infecciones por Papillomavirus/patología , Reacción en Cadena de la Polimerasa , Infecciones Tumorales por Virus/patología , Adulto , Secuencia de Aminoácidos/genética , Secuencia de Bases/genética , Biopsia , ADN Viral/genética , Epidermodisplasia Verruciforme/virología , Humanos , Datos de Secuencia Molecular , Papillomaviridae/genética , Infecciones por Papillomavirus/virología , Piel/patología , Infecciones Tumorales por Virus/virología
10.
Gene Ther ; 3(4): 315-22, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8732163

RESUMEN

The herpes simplex virus thymidine kinase gene was transferred into C6 glioma cells by infection with a recombinant adenovirus. In vitro, a 10 microM ganciclovir concentration was able to kill 100% of the infected cells. For in vivo experiments, brain tumors were established by stereotactic injection of C6 glioma cells in the caudate nucleus of rats. Five days later, the recombinant adenovirus was inoculated into the tumors and the animals were treated by intraperitoneal injections of ganciclovir for 14 days. At the end of ganciclovir therapy, histological examination revealed a 28-fold decrease in tumor volumes in the treated animals, as compared with control animals. In long-term studies, the mean survival time of the treated animals were four-fold longer than that of control ones. Magnetic resonance imaging demonstrated an apparent complete tumor regression in 62% of the animals. However, late tumor recurrence was observed in the treated animals. Repeated inoculation of C6 glioma cells in the contralateral hemisphere of long-term surviving animals resulted in either tumor rejection or slowly growing tumors. These findings demonstrate the potential efficacy of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration in the treatment of rat gliomas.


Asunto(s)
Neoplasias Encefálicas/terapia , Terapia Genética/métodos , Glioma/terapia , Timidina Quinasa/genética , Adenoviridae/genética , Animales , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patología , Ganciclovir/uso terapéutico , Técnicas de Transferencia de Gen , Genes Virales , Vectores Genéticos , Glioma/genética , Glioma/patología , Imagen por Resonancia Magnética , Masculino , Ratas , Ratas Wistar , Simplexvirus/genética , Factores de Tiempo
11.
J Med Genet ; 32(8): 597-9, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7473649

RESUMEN

A follow up study of a cohort of 280 Down's syndrome (DS) fetuses was initiated in order to estimate the percentage of terminations of pregnancy, the prevalence at birth, the survival of DS children, the attitude of the parents at birth, and the medical and surgical care provided. The present study is a preliminary analysis of the data collected up to the age of 1 year. It shows that 43% of the 280 DS fetuses had died by the end of the first year of life, owing to termination of pregnancy (27%), late spontaneous abortion or stillbirth (4%), or death during the first year of life (12%). Among the 33 children who died, 12 had a common atrioventricular canal, six had another major malformation, three died from infection, one from respiratory distress, two were cot deaths, and one was an infanticide, but eight deaths were unexplained, occurring in children with no known malformation or disease. Among the 185 children still alive after 2 days, 23 (12%) were available for adoption, their mothers having elected to remain anonymous. These results show that in some instances parents or professionals feel justified on one hand in not providing DS children with the necessary care and on the other hand to transfer their responsibilities to the public health system. The influence of prenatal diagnosis of chromosome disorders as a determining factor of the social acceptance of DS is still questionable.


Asunto(s)
Síndrome de Down , Padres/psicología , Aborto Inducido , Adopción , Actitud Frente a la Salud , Estudios de Cohortes , Síndrome de Down/epidemiología , Síndrome de Down/mortalidad , Femenino , Muerte Fetal , Estudios de Seguimiento , Francia , Humanos , Recién Nacido , Masculino , Embarazo , Diagnóstico Prenatal , Prevalencia , Sistema de Registros , Tasa de Supervivencia
13.
J Neurooncol ; 24(3): 259-65, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7595756

RESUMEN

Using a rat C6 brain tumor model, we studied the antitumor effects of Herpes simplex virus type 1 thymidine kinase (HSV-tk) gene transfer followed by ganciclovir treatment. C6 glioma cells were transfected in vitro with the HSV-tk gene, and tested for their sensitivity to ganciclovir. Although there was no surviving cell at a 30 microM ganciclovir concentration, unmodified C6 cells were not affected by the drug. For in vivo experiments, intracerebral tumors were induced in rats by stereotactic injection of 10(4) HSV-tk-modified C6 cells. Ten days later, the animals were treated with intraperitoneal injections of ganciclovir for 21 days. The tumors evolution was evaluated by high resolution magnetic resonance imaging. In 33% of the rats, the signal intensity of the tumors became heterogeneous, with development of highly hyperintense areas, and a complete tumor regression was subsequently noted. Histological examination of successfully treated tumors revealed progressive necrosis with formation of cysts. The survival time of the HSV-tk/ganciclovir treated animals was consistently increased, all rats surviving more than 30 days and 33% of them being still alive after 80 days.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Encefálicas/tratamiento farmacológico , Glioma/tratamiento farmacológico , Imagen por Resonancia Magnética , Simplexvirus/enzimología , Animales , Neoplasias Encefálicas/patología , Modelos Animales de Enfermedad , Ganciclovir/uso terapéutico , Técnicas de Transferencia de Gen , Glioma/patología , Masculino , Estadificación de Neoplasias , Trasplante de Neoplasias , Ratas , Ratas Wistar , Reproducibilidad de los Resultados , Tasa de Supervivencia , Timidina Quinasa/genética , Timidina Quinasa/uso terapéutico
14.
J Epidemiol Community Health ; 48(3): 290-6, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8051530

RESUMEN

STUDY OBJECTIVE: The aims were (1) to assess whether termination of pregnancy after prenatal screening by ultrasound affected the prevalence of congenital anomalies at birth, and (2) to examine the trend of this pattern over time. DESIGN: This study deals with congenital anomalies, possibly detectable prenatally or at birth, which were classified as isolated and multiple anomalies; chromosomal anomalies were not included. The prevalence rates of congenital anomalies at birth were determined from case registration data in the Marseille district, France, from the registry of congenital malformations (Eurocat no 22), which covers 23,500 births a year. The chi 2 test for homogeneity in proportions was used to test whether the differences in the total prevalence rates were significant over time. SETTING: The population was defined as all children born to parents living in the Marseille district between January 1 1984 and December 31 1990. PATIENTS: Among the 164,509 pregnancy outcomes monitored during the study, 1795 children with a single congenital anomaly and 288 with multiple congenital anomalies detectable at birth were assessed. MEASUREMENTS AND MAIN RESULTS: The percentage of pregnancy terminations was higher in the case of multiple anomalies (16%) than with single ones (7.5%). Leaving aside the lethal birth defects, this percentage became 7.9% in the case of multiple anomalies and 4.3% with isolated ones. A significant increase (p < 0.001) occurred over the seven year study period in the total percentage of terminations because of isolated anomalies but not in that involving multiple ones. The increase observed in the former case was found to be mainly attributable to an increase in the number of terminations of pregnancy undertaken because of anomalies which were either lethal or associated with very low survival rates (p < 0.001). CONCLUSIONS: Termination of pregnancy after prenatal ultrasound examination was found to have a definite impact on the prevalence at birth of lethal and congenital anomalies with a low survival rate, and this impact tended to increase over time. No such impact was observed in the case of congenital anomalies associated with high survival rates.


Asunto(s)
Anomalías Congénitas/diagnóstico por imagen , Ultrasonografía Prenatal , Anomalías Múltiples/epidemiología , Aborto Inducido , Anomalías Congénitas/epidemiología , Femenino , Muerte Fetal/epidemiología , Francia/epidemiología , Humanos , Recién Nacido , Embarazo , Resultado del Embarazo , Prevalencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA